HP
CLMT icon

Harvey Partners’s Calumet Specialty Products CLMT Stock Holding History

Harvey Partners’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,395
Closed -$269K – 58
2014
Q1 		$269K Buy
+10,395
New +$284K 0.13% 58

Other funds holding CLMT

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
IMS
Index Management Solutions Philadelphia, Pennsylvania $101M AUM 12.09% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
CA
Corrado Advisors Ramsey, New Jersey $192M AUM 20.53% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Harvey Partners's CLMT Position: Q2 2014 in Review

Harvey Partners sold out of Calumet Specialty Products (CLMT) in Q2 2014, closing a stake of 10,395 shares — an estimated $269K sold.

Harvey Partners first reported a position in CLMT in Q1 2014 and held it in 1 quarter. The position peaked at $269K in Q1 2014. 124 funds tracked by Wall St. Rank hold CLMT as of Q2 2014.

  • Harvey Partners reported no remaining Calumet Specialty Products position as of Q2 2014 after selling out during the quarter.
  • Harvey Partners sold 10,395 Calumet Specialty Products shares in Q2 2014, an estimated $269K.
  • Harvey Partners first reported a position in Calumet Specialty Products in Q1 2014 and held it in 1 quarter.
  • Harvey Partners's Calumet Specialty Products position peaked at $269K in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2014.

Based on Harvey Partners's 13F filing for Q2 2014, filed 14 Aug 2014.